alpha-Glucosidase inhibitor acarbose and sequestome 1/A170/p62 deficient mice: A promising therapy and unique model for non-alcoholic fatty liver disease.
Uto
Hirofumi
H
Department of Digestive and Lifestyle-related Disease, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.